Xtrackers Stoxx European Market Leaders UCITS ETF 1C (XZEC)

I’m keeping my focus on Argentina Gold mines. Newmont, but specifically FSM due to the price drop. I think South America will lead the world. Less drama too.

I can’t lose my grip on my LNG to load the boat. Gold takes time.

$MAJI Acquisitions bring immediate $135,000 in monthly recurring revenue prior to near-term scaling initiatives; Transaction structured as non-dilutive to MAJI shareholders. https://seekingalpha.com/pr/20537528-nextel-medical-corp-executes-definitive-purchase-agreements-to-acquire-jumpstartrx-and

$MAJI Acquisitions bring immediate $135,000 in monthly recurring revenue prior to near-term scaling initiatives; Transaction structured as non-dilutive to MAJI shareholders. https://seekingalpha.com/pr/20537528-nextel-medical-corp-executes-definitive-purchase-agreements-to-acquire-jumpstartrx-and

PTOP Secures Largest Enterprise Opportunity in Company History With BostonApartments.com(R) - Here is How It Will Operate

https://www.accessnewswire.com/newsroom/en/computers-technology-and-internet/ptop-secures-largest-enterprise-opportunity-in-company-history-wi-1174872

Every time Trump mentions the evaluation now we drop, very similar to Pulte’s TV appearance’s.

Getting crazier by the day !

$BURU NUBURU Files Golden Power Notification for Majority Acquisition of Tekne, Launching Formal Review by the Italian Government

Golden Power Filing Initiates Review of NUBURU’s Planned Majority Acquisition of Tekne, Supporting Approximately US$459 Million of Pro Rata Exposure to Tek

$BURU NUBURU Files Golden Power Notification for Majority Acquisition of Tekne, Launching Formal Review by the Italian Government

Golden Power Filing Initiates Review of NUBURU’s Planned Majority Acquisition of Tekne, Supporting Approximately US$459 Million of Pro Rata Exposure to Tek

Wouldn’t re-listing the GSEs greatly enhance transparency of share trading? Why does this Administration not work towards transparency?

agq
buying AGQ on the open.

Good interview. https://podcasts.apple.com/us/podcast/interview-on-amfn-with-executive-chairman-of/id1459370287?i=1000771261150

I was there but you were not just saying.

🌐UNCHANGED OUTSTANDING SHARES 6/10/26

Outstanding Shares 160,236,914 03/11/2026
Restricted 101,420 03/11/2026
Unrestricted 160,135,494 03/11/2026
Held at DTC 160,135,494 03/11/2026
Authorized Share 500,000,000 03/11/2026

CytoDyn Announces First Patient Dosed in Phase 2a Study in Collaboration with Weill Cornell Medicine Evaluating Leronlimab in Alzheimer’s Disease
Download as PDFJune 11, 2026 8:30am EDT
Phase 2a study will evaluate the safety and biological activity of leronlimab in patients over the

cydy with cornell uniersity will use our drug to do phase 2 study on alzheimer disease.

LWLG Polymers will solve NVIDIA's MRR (micro-ring resonator modulators) issues!!

Reducing Power Consumption and the Need for Heater ICs: NVIDIA's MRR technology, while highly compact, is susceptible to thermal drift. This means that as the temperature changes, the resonant frequency o

PPCB Buyback News:

Propanc Biopharma, Inc. (NASDAQ:PPCB) ("Propanc" or the "Company"), a biopharmaceutical company focused on developing novel treatments for chronic diseases, including recurrent and metastatic cancer, today announced it has approved a share repurchase program authori

They certainly have been pounding the price the last 4 days:

https://www.cmegroup.com/markets/metals/precious/silver.volume.html

New?

had the same downgrade happen to a different position- OTC error.

https://x.com/vivosincusa/status/2065050253129331078?s=46&t=MFPDnhLdbuc8M9UmbDfCTw

https://www.linkedin.com/posts/diesel-marketing_investor-presentation-activity-7470787948720869377-PtAR?utm_source=share&utm_medium=member_android&rcm=ACoAAAFYb90BO4fY8BCiB31JXid7ZGW_VhVEiac
Sparc and $HGRAF is official. Putting us in there next to some big names.

Another new 52 week low coming? It seems inevitable.

Where else can a revolutionary new material go but up?

Immuneering Announces First Patient Dosed in Pivotal Phase 3 MAPKeeper 301 Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer


https://ir.immuneering.com/news-releases/news-release-details/immuneering-announces-first-patient-dosed-pivotal-phase-3

$ARTM News- American Nortel Provides India Operations Update: Technology Infrastructure and Data Systems Positioned to Support Continued Sales Growth
https://www.otcmarkets.com/stock/ARTM/news/American-Nortel-Provides-India-Operations-Update-Technology-Infrastructure-and-Data-Systems-Position